Literature DB >> 29848111

Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.

Shayne N Hassler1, Fatima B Ahmad1, Carolina C Burgos-Vega1, Scott Boitano2,3,4, Josef Vagner4, Theodore J Price1, Gregory Dussor1.   

Abstract

BACKGROUND: Pain is the most debilitating symptom of migraine. The cause of migraine pain likely requires activation of meningeal nociceptors. Mast cell degranulation, with subsequent meningeal nociceptor activation, has been implicated in migraine pathophysiology. Degranulating mast cells release serine proteases that can cleave and activate protease activated receptors. The purpose of these studies was to investigate whether protease activated receptor 2 is a potential generator of nociceptive input from the meninges by using selective pharmacological agents and knockout mice.
METHODS: Ratiometric Ca++ imaging was performed on primary trigeminal and dural cell cultures after application of 2at-LIGRL-NH2, a specific protease activated receptor 2 agonist. Cutaneous hypersensitivity and facial grimace was measured in wild-type and protease activated receptor 2-/- mice after dural application of 2at-LIGRL-NH2 or compound 48-80, a mast cell degranulator. Behavioral experiments were also conducted in mice after dural application of 2at-LIGRL-NH2 (2AT) in the presence of either C391, a selective protease activated receptor 2 antagonist, or sumatriptan.
RESULTS: 2at-LIGRL-NH2 evoked Ca2+ signaling in mouse trigeminal neurons, dural fibroblasts and in meningeal afferents. Dural application of 2at-LIGRL-NH2 or 48-80 caused dose-dependent grimace behavior and mechanical allodynia that were attenuated by either local or systemic application of C391 as well as in protease activated receptor 2-/- mice. Nociceptive behavior after dural injection of 2at-LIGRL-NH2 was also attenuated by sumatriptan.
CONCLUSIONS: Functional protease activated receptor 2 receptors are expressed on both dural afferents and fibroblasts and activation of dural protease activated receptor 2 produces migraine-like behavioral responses. Protease activated receptor 2 may link resident immune cells to meningeal nociceptor activation, driving migraine-like pain and implicating protease activated receptor 2 as a therapeutic target for migraine in humans.

Entities:  

Keywords:  Protease activated receptor 2 (PAR2); dural nociceptor; mast cell; migraine; trigeminal nerve

Mesh:

Substances:

Year:  2018        PMID: 29848111      PMCID: PMC6081257          DOI: 10.1177/0333102418779548

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  40 in total

1.  Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2.

Authors:  D Zhang; A Spielmann; L Wang; G Ding; F Huang; Q Gu; W Schwarz
Journal:  Physiol Res       Date:  2011-05-16       Impact factor: 1.881

Review 2.  Neuroendocrinology of mast cells: Challenges and controversies.

Authors:  Theoharis C Theoharides
Journal:  Exp Dermatol       Date:  2017-04-02       Impact factor: 3.960

Review 3.  Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine.

Authors:  R Burstein; D Levy; M Jakubowski
Journal:  Rev Neurol (Paris)       Date:  2005-07       Impact factor: 2.607

4.  The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.

Authors:  Scott Boitano; Justin Hoffman; Andrea N Flynn; Marina N Asiedu; Dipti V Tillu; Zhenyu Zhang; Cara L Sherwood; Candy M Rivas; Kathryn A DeFea; Josef Vagner; Theodore J Price
Journal:  Br J Pharmacol       Date:  2015-08-03       Impact factor: 8.739

5.  The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia.

Authors:  Qin Liu; Hao-Jui Weng; Kush N Patel; Zongxiang Tang; Haihua Bai; Martin Steinhoff; Xinzhong Dong
Journal:  Sci Signal       Date:  2011-07-12       Impact factor: 8.192

6.  Spreading depression triggers headache by activating neuronal Panx1 channels.

Authors:  Hulya Karatas; Sefik Evren Erdener; Yasemin Gursoy-Ozdemir; Sevda Lule; Emine Eren-Koçak; Zümrüt Duygu Sen; Turgay Dalkara
Journal:  Science       Date:  2013-03-01       Impact factor: 47.728

7.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

8.  Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering.

Authors:  Scott Boitano; Justin Hoffman; Dipti V Tillu; Marina N Asiedu; Zhenyu Zhang; Cara L Sherwood; Yan Wang; Xinzhong Dong; Theodore J Price; Josef Vagner
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

9.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.

Authors:  T Lieu; E Savage; P Zhao; L Edgington-Mitchell; N Barlow; R Bron; D P Poole; P McLean; R-J Lohman; D P Fairlie; N W Bunnett
Journal:  Br J Pharmacol       Date:  2016-08-03       Impact factor: 8.739

View more
  14 in total

1.  Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.

Authors:  Amanda Avona; Carolina Burgos-Vega; Michael D Burton; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

2.  The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain.

Authors:  Shayne N Hassler; Moeno Kume; Juliet M Mwirigi; Ayesha Ahmad; Stephanie Shiers; Andi Wangzhou; Pradipta R Ray; Serge N Belugin; Dhananjay K Naik; Michael D Burton; Josef Vagner; Scott Boitano; Armen N Akopian; Gregory Dussor; Theodore J Price
Journal:  JCI Insight       Date:  2020-06-04

3.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

4.  A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist.

Authors:  Juliet Mwirigi; Moeno Kume; Shayne N Hassler; Ayesha Ahmad; Pradipta R Ray; Changyu Jiang; Alexander Chamessian; Nakleh Mseeh; Breya P Ludwig; Benjamin D Rivera; Marvin T Nieman; Thomas Van de Ven; Ru-Rong Ji; Gregory Dussor; Scott Boitano; Josef Vagner; Theodore J Price
Journal:  J Pain       Date:  2021-01-09       Impact factor: 5.383

5.  Translating Outcomes from the Clinical Setting to Preclinical Models: Chronic Pain and Functionality in Chronic Musculoskeletal Pain.

Authors:  Melissa E Lenert; Rachelle Gomez; Brandon T Lane; Dana L Dailey; Carol G T Vance; Barbara A Rakel; Leslie J Crofford; Kathleen A Sluka; Ericka N Merriwether; Michael D Burton
Journal:  Pain Med       Date:  2022-09-30       Impact factor: 3.637

6.  Voluntary Wheel Running Partially Attenuates Early Life Stress-Induced Neuroimmune Measures in the Dura and Evoked Migraine-Like Behaviors in Female Mice.

Authors:  Olivia C Eller; Xiaofang Yang; Isabella M Fuentes; Angela N Pierce; Brittni M Jones; Aaron D Brake; Ruipeng Wang; Gregory Dussor; Julie A Christianson
Journal:  Front Physiol       Date:  2021-05-28       Impact factor: 4.566

7.  Involvement of Mast Cells in the Pathophysiology of Pain.

Authors:  Lijia Mai; Qing Liu; Fang Huang; Hongwen He; Wenguo Fan
Journal:  Front Cell Neurosci       Date:  2021-06-10       Impact factor: 5.505

8.  Sensory Neuron TLR4 mediates the development of nerve-injury induced mechanical hypersensitivity in female mice.

Authors:  Thomas A Szabo-Pardi; Luz R Barron; Melissa E Lenert; Michael D Burton
Journal:  Brain Behav Immun       Date:  2021-06-23       Impact factor: 19.227

9.  Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.

Authors:  Camila Ritter; Diéssica Padilha Dalenogare; Amanda Spring de Almeida; Vitória Loreto Pereira; Gabriele Cheiran Pereira; Maria Fernanda Pessano Fialho; Débora Denardin Lückemeyer; Caren Tatiane Antoniazzi; Sabrina Qader Kudsi; Juliano Ferreira; Sara Marchesan Oliveira; Gabriela Trevisan
Journal:  Mol Neurobiol       Date:  2020-02-24       Impact factor: 5.590

Review 10.  Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology.

Authors:  Mamoru Shibata; Chunhua Tang
Journal:  Neurosci Bull       Date:  2020-09-01       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.